SMMT

Summit Therapeutics Inc
3.02
-0.12 (-3.82%)
Company Name Stock Ticker Symbol Market Type
Summit Therapeutics Inc SMMT NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
-0.12 -3.82% 3.02 19:55:33
Open Price Low Price High Price Close Price Prev Close
3.12 2.88 3.33 2.98 3.14
more quote information »

Recent News

Date Time Source Heading
2/06/20239:30IHNWFeaturedHempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201
1/30/202316:13EDGARCurrent Report Filing (8-k)
1/30/202308:00BWSummit Therapeutics Announces Timing for Rights Offering for..
1/27/202316:07EDGARCurrent Report Filing (8-k)
1/26/202314:50EDGARInitial Statement of Beneficial Ownership (3)
1/23/202306:04EDGARSecurities Registration Statement (simplified Form) (s-3/a)
1/20/202317:16EDGARCurrent Report Filing (8-k)
1/20/202308:00BWSummit Therapeutics Closes Deal with Akeso Inc. to..
1/09/202316:35EDGARCurrent Report Filing (8-k)
1/05/202316:22EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:13EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202316:10EDGARStatement of Changes in Beneficial Ownership (4)
1/05/202307:00BWSummit Therapeutics to Present at the 41st Annual J.P...
12/27/202216:07EDGARCurrent Report Filing (8-k)
12/21/202217:02EDGARCurrent Report Filing (8-k)
12/21/202216:52EDGARSecurities Registration Statement (simplified Form) (s-3)
12/13/202216:07EDGARProxy Statement (definitive) (def 14a)
12/09/202217:25EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/08/202218:29EDGARStatement of Changes in Beneficial Ownership (4)
12/06/202216:57EDGARCurrent Report Filing (8-k)
12/06/202216:46TRMNSummit Therapeutics Explodes Up on Licensing Deal
12/06/202207:30GLOBESummit Therapeutics Partners with Akeso Inc. in Deal for Up..
11/17/202216:25EDGARInitial Statement of Beneficial Ownership (3)
11/17/202216:15GLOBESummit Therapeutics Appoints Experienced Clinical Leader Dr...
11/09/202216:25EDGARQuarterly Report (10-q)
11/09/202208:30GLOBESummit Therapeutics Inc. Reports Financial Results and..
10/20/202217:15GLOBESummit Therapeutics Presents Ri-CoDIFy Trial Results for..
10/13/202208:00GLOBESummit Therapeutics to Present Ri-CoDIFy Trial Results for..
10/04/202208:03EDGARCurrent Report Filing (8-k)
10/03/202216:36GLOBESummit Therapeutics Appoints Dr. Robert Booth, Renowned..
8/18/202216:43EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/18/202216:37EDGARStatement of Changes in Beneficial Ownership (4)
8/17/202216:50EDGARStatement of Changes in Beneficial Ownership (4)
8/16/202216:32EDGARCurrent Report Filing (8-k)
8/11/202216:18EDGARCurrent Report Filing (8-k)
8/11/202216:11EDGARQuarterly Report (10-q)
8/11/202208:00GLOBESummit Therapeutics Inc Reports Financial Results and..
8/09/202215:36EDGARCurrent Report Filing (8-k)
8/09/202213:37GLOBESummit Therapeutics Closes Fully-Subscribed $100 Million..
8/02/202209:25GLOBESummit Therapeutics’ Rights Offering Nearing Expiration Date
7/26/202216:32EDGARCurrent Report Filing (8-k)
7/26/202216:15GLOBESummit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO &..
7/18/202216:18EDGARCurrent Report Filing (8-k)
7/18/202216:05GLOBESummit Therapeutics Announces Commencement of $100 Million..
7/18/202215:50EDGARProspectus Filed Pursuant to Rule 424(b)(4) (424b4)
7/14/202208:30GLOBESummit Therapeutics Provides Update on Ridinilazole
7/07/202210:26EDGARProxy Statement (definitive) (def 14a)
6/22/202216:37EDGARCurrent Report Filing (8-k)
6/22/202216:30GLOBESummit Therapeutics Announces $100 Million Rights Offering
6/03/202216:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/03/202208:30GLOBESummit Therapeutics’ Upcoming Annual Shareholders’ Meeting